HB 229 KY

0likes☆Favorite🔕SubscribeShare

Introduced

Create a new section of KRS 217.005 to 217.215, the Kentucky Food, Drug, and Cosmetic Act, to define terms; require products that are known to be or could act as gene therapy to be labeled with the words "Potential Gene Therapy Product" or "Gene Therapy Product"; require any entity in the state that produces, sells, or distributes a product in this state with the capacity to infect an individual with a disease or to expose an individual with genetically modified material to provide information upon request on how individuals may be exposed; require informed consent before any entity makes available a product in this state that would act as a medical intervention, vaccine, drug, or genetic modification.

• E. Callaway Republican · primary
• J. Decker Republican · primary
• D. Bentley · primary
• J. Hodgson Republican · primary
• M. Proctor Republican · primary
• S. Rawlings Republican · primary

1. Jan 10, 2024 introduced in House · lower
2. Jan 10, 2024 to Committee on Committees (H) · lower

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

• Introduced · PDF